回盛生物跌2.03%，成交额7294.51万元，主力资金净流出392.34万元

Core Viewpoint - The stock of Wuhan Kewen Biological Technology Co., Ltd. (回盛生物) has experienced fluctuations, with a year-to-date increase of 120.22% and recent trading activity indicating a slight decline. The company operates in the veterinary pharmaceuticals sector, focusing on the research, production, and sales of veterinary drugs and feed additives [1][2]. Financial Performance - For the period from January to September 2025, the company achieved a revenue of 1.26 billion yuan, representing a year-on-year growth of 58.92%. The net profit attributable to shareholders reached 188 million yuan, showing a significant increase of 494.28% compared to the previous year [2]. - Cumulatively, since its A-share listing, the company has distributed a total of 236 million yuan in dividends, with 135 million yuan distributed over the past three years [3]. Stock Market Activity - As of November 12, the stock price was 21.70 yuan per share, with a market capitalization of 4.39 billion yuan. The stock has seen a trading volume of 72.95 million yuan and a turnover rate of 1.65% [1]. - The company has appeared on the "龙虎榜" (a stock trading list) seven times this year, with the most recent appearance on April 9, where it recorded a net buy of -65.95 million yuan [1]. Shareholder Information - As of September 30, the number of shareholders stood at 21,200, a decrease of 10.03% from the previous period. The average number of circulating shares per shareholder increased by 11.15% to 9,566 shares [2].